Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression
NCT ID: NCT02503124
Last Updated: 2021-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
32 participants
INTERVENTIONAL
2015-07-31
2020-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wake and Light Therapy to In-patients With Major Depression: Efficacy, Predictors and Patient Experiences
NCT02047968
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
NCT00852592
Bright Light Therapy in Seasonal Affective Disorder (SAD)
NCT01293409
ROOM-LIGHT: Effect of a Dynamic Lighting System in Depressed Inpatients
NCT03821506
Bright Light Therapy in Seasonal Affective Disorder (SAD)
NCT01030276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronobiological intervention
Single night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual.
Single night's wake therapy
Eligible patients are assisted in maintaining total sleep deprivation during one night
Bright light
Bright light according to patients´ own circadian rhythm each morning for a week.
Treatment as usual - inpatient care
All patients are admitted due to severe depression and are under observation and most receive antidepressive medication and if necessary anxiolytic/antipsychotic medication.
Treatment as usual - medicine
Since all patients are admitted due to a severe mental illness, they will receive medication according to indication. Most patients have already tried more than one antidepressant at the time of admission. In cases of severe anxiety, anxiolytics are prescribed but this is kept to a minimum.
Control
Treatment as usual including a private educational meeting in sleep hygiene.
Treatment as usual - inpatient care
All patients are admitted due to severe depression and are under observation and most receive antidepressive medication and if necessary anxiolytic/antipsychotic medication.
Informative meeting
A short sleep hygiene consultation.
Treatment as usual - medicine
Since all patients are admitted due to a severe mental illness, they will receive medication according to indication. Most patients have already tried more than one antidepressant at the time of admission. In cases of severe anxiety, anxiolytics are prescribed but this is kept to a minimum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single night's wake therapy
Eligible patients are assisted in maintaining total sleep deprivation during one night
Bright light
Bright light according to patients´ own circadian rhythm each morning for a week.
Treatment as usual - inpatient care
All patients are admitted due to severe depression and are under observation and most receive antidepressive medication and if necessary anxiolytic/antipsychotic medication.
Informative meeting
A short sleep hygiene consultation.
Treatment as usual - medicine
Since all patients are admitted due to a severe mental illness, they will receive medication according to indication. Most patients have already tried more than one antidepressant at the time of admission. In cases of severe anxiety, anxiolytics are prescribed but this is kept to a minimum.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Compulsory admission
* Confusion
* Active substance use disorder
* Eye disease preventing bright light therapy
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steinn Steingrimsson
MD, PhD, resident in psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steinn Steingrimsson, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CB001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.